Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Hay

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|June 27, 1992
Purity of factor VIII concentratesC R Hay, P McEvoy
Seminars in Thrombosis and Hemostasis|November 25, 2000
The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIaC Negrier, C R Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Editorial ForewordL M Aledort, C R Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Early rapid decline in CD4 count reversed by splenectomy in HIV infectionA M McKernan, C R Hay
Transfusion Medicine Reviews|October 1, 1991
Porcine factor VIIIC in the management of patients with factor VIII inhibitorsC R Hay, P Bolton-Maggs
The Biochemical Journal|December 1, 1996
Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-integrin by the snake venom metalloproteinase jararhaginA S Kamiguti, C R Hay, M Zuzel
British Journal of Haematology|June 1, 1990
Inhibition of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immunosuppression in haemophiliacsC R Hay, P McEvoy, M Duggan-Keen
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Didanosine treatment of haemophilic patients infected with HIVJ T Wilde, A McKernan, C R Hay
Thrombosis and Haemostasis|January 10, 1998
The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre studyC R Hay, C Negrier, C A Ludlam
BMJ (Clinical Research Ed.)|March 8, 1997
Treatment for haemophilia by postcodeC A Ludlam, C R Hay, G Dolan
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|June 27, 1992
Purity of factor VIII concentratesC R Hay, P McEvoy
Seminars in Thrombosis and Hemostasis|November 25, 2000
The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIaC Negrier, C R Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Editorial ForewordL M Aledort, C R Hay
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Early rapid decline in CD4 count reversed by splenectomy in HIV infectionA M McKernan, C R Hay
Transfusion Medicine Reviews|October 1, 1991
Porcine factor VIIIC in the management of patients with factor VIII inhibitorsC R Hay, P Bolton-Maggs
The Biochemical Journal|December 1, 1996
Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-integrin by the snake venom metalloproteinase jararhaginA S Kamiguti, C R Hay, M Zuzel
British Journal of Haematology|June 1, 1990
Inhibition of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immunosuppression in haemophiliacsC R Hay, P McEvoy, M Duggan-Keen
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Didanosine treatment of haemophilic patients infected with HIVJ T Wilde, A McKernan, C R Hay
Thrombosis and Haemostasis|January 10, 1998
The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre studyC R Hay, C Negrier, C A Ludlam
BMJ (Clinical Research Ed.)|March 8, 1997
Treatment for haemophilia by postcodeC A Ludlam, C R Hay, G Dolan
Pageof 7